Skip to content

Exercise Training to Improve Physical Functioning and Exercise Adoption in Lung Cancer Survivors: a Randomized Controlled Trial

Exercise Training to Improve Physical Functioning and Exercise Adoption in Lung Cancer Survivors: a Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612000076875
Enrollment
36
Registered
2012-01-16
Start date
2012-02-15
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aims to determine the effect of supervised and home-based exercise training in lung cancer survivors. Who is it for? You may be eligible to join this study if you have been diagnosed with lung cancer and are no longer on treatment. Trial details. Participants in this trial will be randomly (by chance) allocated to one of two groups. One group will undergo supervised and home-based exercise training. This involves resistance (lifting weights) and aerobic exercise (walking), three times per week over a period of 3 months and then will be monitored (without training) for a further 3 months. The other group will be assigned to no treatment for the first 3 months. After this time participants in this group will be given a home-based exercise program and equipment. Participants will complete some tests of physical function and questionnaires about fatigue, and physical activity levels, and have their body composition measured at these time points. It is thought that the exercise program will improve physical function when compared to no training.

Interventions

Exercise Group: Participants randomized to the exercise arm will receive 12-weeks of supervised and home-based exercise training. For the first 8-weeks, supervised training will take place twice weekly. The supervised exercise will take approximately 60 minutes, and will include resistance training (6 exercises; 12-6 RM), and aerobic training (walking; 60-85% HRmax). Home-based walking will be progressively prescribed during this time (from 1-3 times a week). For the final month participants

Exercise Group: Participants randomized to the exercise arm will receive 12-weeks of supervised and home-based exercise training. For the first 8-weeks, supervised training will take place twice weekly. The supervised exercise will take approximately 60 minutes, and will include resistance training (6 exercises; 12-6 RM), and aerobic training (walking; 60-85% HRmax). Home-based walking will be progressively prescribed during this time (from 1-3 times a week). For the final month participants will undergo one supervised exercise training session, and one home-based resistance training session, as well as home-based walking up to three times per week. The exercise program will be individually prescribed relative to the individuals health and fitness, but will be based on a standard program.

Sponsors

Edith Cowan University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Confirmed stage I-IIIB non-small cell lung cancer or limited stage small cell lung cancer and not currently on treatment for cancer.

Exclusion criteria

Participating in regular exercise (performing 150 minutes of aerobic exercise and resistance exercise 2 days/week) within the past 3 months. Any musculoskeletal, neurological, or cardiovascular disorder that could inhibit exercise or put them at risk of injury or illness. Metastatic disease or presence of bone metastases.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026